Yahoo Science News feed latest items
British officials announced Wednesday that they have charged two alleged Russian military intelligence agents with the nerve agent poisoning of ex-spy Sergei Skripal and his daughter Yulia in the English city of Salisbury.
Early, partial results from a historic gene editing study give encouraging signs that the treatment may be safe and having at least some of its hoped-for effect, but it's too soon to know whether it ultimately will succeed. The results announced Wednesday are from the first human test of gene editing in the body, an attempt to permanently change someone's DNA to cure a disease — in this case, a genetic disorder called Hunter syndrome that often kills people in their teens. In two patients who got a medium dose of the treatment, urine levels of large sugar compounds that are hallmarks of Hunter syndrome had fallen by half, on average, four months later — a possible sign the treatment is working.
Mexico, Sep. 5 (Notimex).- The ATTRACT initiative will invest 17 million euros, destined to projects that develop innovative ideas in detection and image technologies in Europe. The project will finance 170 innovative ideas that have the potential to reach the market to create products, services, companies and jobs based on new detection and image technologies. In this sense, the European Southern Observatory (ESO), performs and operates cutting-edge terrestrial astronomical telescopes, and as an ATTRACT partner, it expects to benefit from advances in detectors. "ATTRACT aims to create and implement mechanisms and a permanent channel to achieve this transformation in a systematic way," said ATTRACT Special Advisor Henry Chesbrough. The call for ATTRACT funds is open to researchers and entrepreneurs of European organizations until October 31, 2018. The 170 innovative projects funded by ATTRACT will have a year to develop their ideas, in this period, the teams will receive help to transform their disruptive technology into innovative advances, with a strong market potential. The ESO indicates that among the future applications for society are: portable scanners for ambulatory treatment; sensors to help people with visual disabilities to move in a better way. In addition to sensor networks to make agriculture more productive with lower energy consumption; improve the ways of learning online; and new ways to monitor the accuracy of climate change. NTX/ICB/LCH/ASTRO16/BBF
BEIJING (AP) — A rocket developed by Chinese company iSpace blasted into space Wednesday carrying three miniature satellites in another milestone for the country's budding private spaceflight industry.
Ambitious action on climate change could contribute an extra $26 trillion to the world economy by 2030, international experts said on Wednesday, urging nations and businesses to step up their engagement. The economic benefits offered by a shift to a low-carbon economy have been "grossly" underestimated, according to the Global Commission on the Economy and Climate, a think tank grouping former heads of government and top economic and business leaders. "Bold action could yield a direct economic gain of $26 trillion through to 2030 compared with business-as-usual.
The bonnethead shark, a small member of the hammerhead family, was long thought to be a strict carnivore that would occasionally ingest greens purely by accident. The bonnethead follows an omnivorous diet in which seagrass plays a key, nutritional role. Although researchers have long known that Sphyrna tiburo eats copious quantities of seagrass, it was not believed to absorb any nutrients from it.
NIH Funding Opportunities
- Notice of Expiration of PA-18-471 "Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)"
- Advance Notice: Streamlining the Certifications and Representations Process and Phasing out the SF-424B
- NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed)
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)